2021-04-22 20:30
The SARS-CoV-2 is a new emerging coronavirus that has not been previously identified in humans. Outbreak of this novel coronaviruses infections among people has raised widespread attention. Treatment with RNA polymerase inhibitors is one way to help
... дальше

2021-04-22 20:30
"Viruses, as a kind of non-cellular structure microorganisms, need to be parasitic in living cells to survive. The first step in its life cycle is adsorption to specific receptors on host cells. In many cases, the specificity of the receptor determin
... дальше

2021-04-22 20:29
The SARS coronavirus, sometimes shortened to SARS-CoV, is the virus that causes severe acute respiratory syndrome (SARS). On April 16, 2003, following the outbreak of SARS in Asia and secondary cases elsewhere in the world, the World Health Organizat
... дальше

2021-04-22 20:29
Emerging infectious diseases are a major threat to human health. In the past 20 years, the epidemics caused by severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and Ebola virus have cau
... дальше

2021-04-22 20:29
Vaccine research and development has become very urgent with the emergence of new diseases, increased burden of infectious disease, and growing concern regarding vaccine safety. Creative Biolabs has more than a decade of experience and deep expertise
... дальше

2021-04-22 20:28
Antiviral drugs are essential for control of initial influenza outbreaks caused by a new virus. The principal target for these drugs is a virus surface glycoprotein, neuraminidase, which facilitates the release of the nascent virus and thus the sprea
... дальше

2021-04-22 20:28
Creative Biolabs is a global, research-based biotechnology company dedicated to the discovery and development of novel viral vaccines. Our researchers are working to improve the design of vaccines and develop novel approaches that can reduce cost and
... дальше

2021-04-22 20:28
As a novel frontier for drug discovery, PROTACs utilize bifunctional small molecules to remove disease-causing proteins, and it has huge potential to offer therapeutic interventions not achievable with existing approaches. Creative Biolabs now posses
... дальше

2021-04-22 20:27
In the early discovery and development phase, drug candidates need to be screened for the cell permeability efficacy to evaluate the absorption potential. With the advanced one-stop PROTAC service platform, Creative Biolabs now provides comprehensive
... дальше